🔎 Trials Near Me

Gara Jalqabaatti › Dhukkubaa Harkaa Steatotic › Texas › Houston

Qorannoo klinikaalii Dhukkubaa Harkaa Steatotic Houston, TX keessatti

Qorannoo 13 Dhukkubaa Harkaa Steatotic f Houston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Namoota walitti qabaa jiraSadarkaa 3
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Bellaire · Miili 7 fagaatti
  • GSK Investigational Site, Humble · Miili 17 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Namoota walitti qabaa jiraSadarkaa 3
  • GSK Investigational Site, Bellaire · Miili 7 fagaatti
  • GSK Investigational Site, Humble · Miili 17 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07701993

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Namoota walitti qabaa jiraSadarkaa 2
  • Pioneer Research Solutions, Inc., Houston
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Namoota walitti qabaa jiraSadarkaa 3
  • HRI- Medical Center, Houston
  • Care Access - Houston, Houston
  • Houston Research Institute, Houston
  • fi 3 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Namoota walitti qabaa jiraSadarkaa 3
  • Akero Clinical Study Site, Houston
  • Akero Clinical Study Site, Houston
  • Akero Clinical Study Site, Houston
  • fi 3 dabalataa
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06528314

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Namoota walitti qabaa jiraSadarkaa 2
  • Houston Research Institute - Medical Center, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, Bellaire · Miili 7 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07288138

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Namoota walitti qabaa jiraSadarkaa 3
  • 89bio Clinical Study Site, Houston
  • 89bio Clinical Study Site, Houston
  • 89bio Clinical Study Site, Houston
  • fi 1 dabalataa
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Namoota walitti qabaa jiraSadarkaa 3
  • 89bio Clinical Study Site, Houston
  • 89bio Clinical Study Site, Houston
  • 89bio Clinical Study Site, Houston
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06419374

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Namoota walitti qabaa jiraSadarkaa 3
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Bellaire · Miili 7 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Namoota walitti qabaa jiraSadarkaa 2
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 08-Ado-2026 · NCT06920043

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
  • Pioneer Research Solutions, Houston
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT05648214

NAFLD Clinical Care Pathway

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Sad-2025 · NCT06671886

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Namoota walitti qabaa jiraQorannoo ilaalaa
  • First Surgical Hospital, Bellaire · Miili 7 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Hag-2025 · NCT07122700

Qorannoo Dhukkubaa Harkaa Steatotic magaalota biroo keessatti

Qorannoo biroo Houston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.